---
title: "Gan & Lee Pharmaceuticals Wins Honduras Drug Registration for Vitaglar Insulin Glargine Prefilled Pen"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292175130.md"
description: "Gan & Lee Pharmaceuticals received drug registration approval in Honduras for its insulin glargine injection (prefilled pen), branded as VITAGLAR, for diabetes treatment. The company highlighted the local market potential, citing a population of 10.82 million and approximately 259,000 diabetic patients aged 20-79 in 2024."
datetime: "2026-07-09T09:07:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292175130.md)
  - [en](https://longbridge.com/en/news/292175130.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292175130.md)
generator: "portal-rs"
---

# Gan & Lee Pharmaceuticals Wins Honduras Drug Registration for Vitaglar Insulin Glargine Prefilled Pen

Gan & Lee Pharmaceuticals said it has received a drug registration approval in Honduras for its insulin glargine injection in a prefilled pen format. According to Jin10, the company announced that it recently obtained a registration certificate issued by Honduras' National Medicines Regulatory Authority for insulin glargine injection (prefilled pen), with approval number HN-BT-0426-0005. The product name is VITAGLAR, with an indication for diabetes. The dosage form is an injectable, with a specification of 3 ml at 100 units/ml (prefilled pen). The company cited Honduras data stating the country has a total population of about 10.82 million and GDP per capita of $3,426.4. It also cited estimates that in 2024, Honduras had about 259,000 people aged 20 to 79 with diabetes, a diabetes prevalence rate of 4.0%, an undiagnosed rate of 51.9%, and average annual diabetes-related spending per patient of $789.4.

### Related Stocks

- [603087.CN](https://longbridge.com/en/quote/603087.CN.md)

## Related News & Research

- [05:37 ETGan & Lee and Menarini Group Partner to Advance Bofanglutide in Europe](https://longbridge.com/en/news/297892423.md)
- [Bipartisan insulin price cap introduced in House as lawmakers seek affordability win](https://longbridge.com/en/news/297951183.md)
- [LIVE MARKETS-Winners and losers from Trump's drug pricing policy](https://longbridge.com/en/news/297905521.md)
- [Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President](https://longbridge.com/en/news/297630906.md)
- [China Resources Pharma unit KPC wins registration to issue RMB 1 billion in medium-term notes](https://longbridge.com/en/news/297630970.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**